orbital extension of supraorbital angiolymphoid hyperplasia with eosinophilia

Clicks: 191
ID: 152986
2011
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #31 of 52 articles by views in translational behavioral medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rareclinicopathologic entity that shares both clinical andhistopathological features with Kimura disease. Although theywere once considered as different stages of the same disease,they are now known to represent separate entities. ALHE is acondition that causes swellings in the head and neck regionaffecting muscular arteries and is benign in nature.1 Orbitalinvolvement is unusual. Diagnosis of ALHE is frequentlyconfused with malignant tumour until biopsy is done.4 Wepresent here a young female with unilateral, painless andslowly progressive swelling on the inner and upper aspect ofher left orbit, who was diagnosed as a case of ALHE withorbital involvement on the basis of CT scan and excisionalbiopsy. Regular follow up was performed and no evidence ofrecurrence was found
Reference Key
sv2011australasianorbital Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Bangal SV;Chitgopekar RP;Gupta AK;Karle R
Journal translational behavioral medicine
Year 2011
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.